Population Exposure‐Response Modeling of Naloxegol in Patients With Noncancer‐Related Pain and Opioid‐Induced Constipation
Naloxegol is a polyethylene glycol derivative of naloxone approved in the US as a once‐daily oral treatment for opioid‐induced constipation (OIC) in adults with chronic noncancer pain. Population exposure–response models were constructed based on data from two phase III studies comprising 1,331 adul...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2016-07-01
|
| Seri Bilgileri: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Erişim: | https://doi.org/10.1002/psp4.12099 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|